KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBIT Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed EBIT Margin for 9 consecutive years, with 31.73% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 733.0% to 31.73% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 34.35% through Dec 2025, up 2879.0% year-over-year, with the annual reading at 36.18% for FY2025, 3437.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 31.73% at Twist Bioscience, down from 30.23% in the prior quarter.
  • The five-year high for EBIT Margin was 30.23% in Q3 2025, with the low at 133.13% in Q4 2021.
  • Average EBIT Margin over 5 years is 81.45%, with a median of 88.82% recorded in 2022.
  • The sharpest move saw EBIT Margin tumbled -3100bps in 2021, then skyrocketed 7780bps in 2025.
  • Over 5 years, EBIT Margin stood at 133.13% in 2021, then skyrocketed by 38bps to 82.28% in 2022, then increased by 20bps to 65.7% in 2023, then skyrocketed by 41bps to 39.05% in 2024, then increased by 19bps to 31.73% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 31.73%, 30.23%, and 31.36% for Q4 2025, Q3 2025, and Q2 2025 respectively.